Work

Successful Management of Patients Receiving Bispecific Antibodies for Hematologic Malignancies

Year: 2025

Type: article

Abstract: As more bispecific antibody therapies are approved, advanced practitioners must be aware of their unique dosing strategies, toxicity profiles, and patient monitoring and coordination requirements. At JADPRO Live 2024, presenters discussed the management of patients receiving bispecific antibodies for hematologic malignancies, highlighting step-up dosing protocols, adverse effects, and the importance of patient education and monitoring.

Source: Journal of the Advanced Practitioner in Oncology

DOI: 10.6004/jadpro.2025.16.2.15

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4409003558

FWCI: 0.545

Cites:

Cited by: 1

Related to: 10